VC-backed Gamida Cell appoints Nobel laureate to board of directors

Jerusalem-based Gamida Cell, a provider of cellular and immune therapies that treat cancer and orphan genetic diseases, has appointed Nobel laureate Roger Kornberg and Dr. Michael Perry, a retired Novartis executive, to its board of directors. A professor of structural biology at Stanford Medical School, Kornberg won the Nobel Prize for Chemistry in 2006. Gamida Cell's backers include Novartis, Elbit Imaging, Clal Biotechnology Industries, Israel Healthcare Venture, Denali Ventures and Auriga Ventures.

North AmericaUSHuman ResourcesBriefs